Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial”.
Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan +12 more
Cora N. Sternberg, Hao Wang, Tingchang Wang, Laura Linville, Catherine H. Marshall +5 more
Benjamin A. Teply, Su Jin Lim, Hao Wang, Shifeng Mao, William Kevin Kelly +10 more